Market Size of Europe Nutraceutical Industry
Study Period | 2018 - 2029 |
Base Year For Estimation | 2023 |
Market Size (2024) | USD 83.88 Billion |
Market Size (2029) | USD 106.59 Billion |
CAGR (2024 - 2029) | 4.91 % |
Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Europe Nutraceutical Market Analysis
The Europe Nutraceutical Market size is estimated at USD 83.88 billion in 2024, and is expected to reach USD 106.59 billion by 2029, growing at a CAGR of 4.91% during the forecast period (2024-2029).
In the European region, nutraceuticals are gaining importance and becoming a part of the consumer's daily diet. The reasons for this change are the increased prevalence of lifestyle-related diseases and people taking preventive healthcare measures. With the increase in life expectancy and subsequent increase in lifestyle-related diseases, nutraceuticals have emerged as a necessity for consumers, especially in a developed market, such as the European region. Functional food is the largest share-holding category of the market, followed by functional beverages and dietary supplements. A functional beverage is the fastest-growing segment, and developing markets have growth potential for these beverages.
Furthermore, due to the high elderly population, the diseases like obesity, heart-related diseases, arthritis, and many more are growing. According to the World Bank data from 2021, about 21.13% of the population in Europe is above the age of 65. Because of this, the region's requirement for nutraceuticals and functional foods is increasing. Also, the requirement for probiotic supplements is increased owing to the rising problems related to digestion, obesity, and others. In October 2022, OptiBiotix Health Plc (OptiBiotix), a global market leader in microbiome modulation solutions, " OptiXOS", a new xylo-oligosaccharide prebiotic for the European and African market. The product claims to increase positive gut health microbes at low active doses.
Europe Nutraceutical Industry Segmentation
Nutraceutical products are substances that have physiological benefits, protect against chronic diseases, improve health, delay aging, and increase life expectancy. The European nutraceuticals market is segmented by product type into functional food, functional beverages, and dietary supplements. By distribution channel, the market is segmented into supermarkets/hypermarkets, convenience stores, specialty stores, online retail stores, and other distribution channels. Based on geography, the market is segmented into the United Kingdom, Germany, France, Spain, Italy, Russia, and the Rest of Europe. For each segment, the market sizing and forecasts have been done based on value (in USD Million).
Product Type | |
Functional Food | |
Functional Beverage | |
Dietary Supplement |
Distribution Channel | |
Supermarkets/Hypermarkets | |
Convenience Stores | |
Speciality Stores | |
Online Retail Stores | |
Other Distribution Channels |
Country | |
United Kingdom | |
Germany | |
France | |
Spain | |
Italy | |
Russia | |
Rest of Europe |
Europe Nutraceutical Market Size Summary
The European nutraceutical market is experiencing significant growth, driven by an increasing consumer focus on health and wellness. This shift is largely attributed to the rising prevalence of lifestyle-related diseases and a growing emphasis on preventive healthcare measures. As life expectancy increases, so does the demand for nutraceuticals, which are becoming integral to daily diets across the region. Functional foods dominate the market, with functional beverages emerging as the fastest-growing segment. The high elderly population in Europe, coupled with health issues such as obesity and heart diseases, is further propelling the demand for these products. Countries like Germany, the United Kingdom, and France are leading the market, with Germany being the largest due to its robust economy and consumer preference for high-quality, health-oriented products.
The market is characterized by intense competition, with numerous international and domestic players such as Nestle SA, The Kelloggs Company, Amway Corporation, Herbalife Nutrition Ltd, and The Coca-Cola Company actively participating. Innovation and new product development are key focus areas, with companies investing heavily in research and development to meet evolving consumer demands. The introduction of probiotic products and functional snack bars, along with the fortification of various food categories, highlights the industry's dynamic nature. The presence of innovation hubs in countries like Germany, the Netherlands, and Sweden is attracting major companies, further enhancing the market's growth prospects. As consumer trends continue to evolve, companies are poised to capitalize on new opportunities, positioning themselves strategically in the competitive landscape.
Europe Nutraceutical Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Drivers
-
1.2 Market Restraints
-
1.3 Porter's Five Forces Analysis
-
1.3.1 Threat of New Entrants
-
1.3.2 Bargaining Power of Buyers/Consumers
-
1.3.3 Bargaining Power of Suppliers
-
1.3.4 Threat of Substitute Products
-
1.3.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Product Type
-
2.1.1 Functional Food
-
2.1.2 Functional Beverage
-
2.1.3 Dietary Supplement
-
-
2.2 Distribution Channel
-
2.2.1 Supermarkets/Hypermarkets
-
2.2.2 Convenience Stores
-
2.2.3 Speciality Stores
-
2.2.4 Online Retail Stores
-
2.2.5 Other Distribution Channels
-
-
2.3 Country
-
2.3.1 United Kingdom
-
2.3.2 Germany
-
2.3.3 France
-
2.3.4 Spain
-
2.3.5 Italy
-
2.3.6 Russia
-
2.3.7 Rest of Europe
-
-
Europe Nutraceutical Market Size FAQs
How big is the Europe Nutraceutical Market?
The Europe Nutraceutical Market size is expected to reach USD 83.88 billion in 2024 and grow at a CAGR of 4.91% to reach USD 106.59 billion by 2029.
What is the current Europe Nutraceutical Market size?
In 2024, the Europe Nutraceutical Market size is expected to reach USD 83.88 billion.